Latest Breaking News On - Psychosom res - Page 2 : comparemela.com
Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Nociplastic pain: towards an understanding of prevalent pain conditions
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Almirall and Happify Health enter into strategic partnership to develop evidence-supported digital therapeutics solutions for psoriasis patients
BARCELONA, Jan. 28, 2021 /PRNewswire/
Almirall, S.A. (BME:ALM)
, a global biopharmaceutical company based in Barcelona, and Happify Health, a leader in digital therapeutics solutions to improve mental and physical health based in New York, will develop a version of its digital platform specifically for people with psoriasis in Spain, UK, Italy and France to be rolled out this year. It is estimated that 20-30% of patients with moderate to severe psoriasis suffer from mental health issues such as anxiety and depression[1]. Happify Health, through evidence-based and clinically validated platforms, delivers mental health solutions targeted to patients with chronic diseases.